James B Bucher - Net Worth and Insider Trading
James B Bucher Net Worth
The estimated net worth of James B Bucher is at least $185,194 dollars as of 2024-06-02. James B Bucher is the EVP & General Counsel of Alder BioPharmaceuticals Inc and owns about 9,809 shares of Alder BioPharmaceuticals Inc (ALDR) stock worth over $185,194. Details can be seen in James B Bucher's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James B Bucher has not made any transactions after 2019-04-25 and currently still holds the listed stock(s).
Transaction Summary of James B Bucher
James B Bucher Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James B Bucher owns 1 companies in total, including Eliem Therapeutics Inc (ELYM) .
Click here to see the complete history of James B Bucher’s form 4 insider trades.
Insider Ownership Summary of James B Bucher
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELYM | Eliem Therapeutics Inc | 2021-08-09 | EVP and General Counsel |
James B Bucher Latest Holdings Summary
James B Bucher currently owns a total of 1 stock. James B Bucher owns 9,809 shares of Alder BioPharmaceuticals Inc (ALDR) as of April 25, 2019, with a value of $185,194.
Latest Holdings of James B Bucher
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALDR | Alder BioPharmaceuticals Inc | 2019-04-25 | 9,809 | 18.88 | 185,194 |
Holding Weightings of James B Bucher
James B Bucher Form 4 Trading Tracker
According to the SEC Form 4 filings, James B Bucher has made a total of 0 transactions in Alder BioPharmaceuticals Inc (ALDR) over the past 5 years. The most-recent trade in Alder BioPharmaceuticals Inc is the sale of 1,897 shares on April 25, 2019, which brought James B Bucher around $26,274.
Insider Trading History of James B Bucher
- 1
James B Bucher Trading Performance
James B Bucher Ownership Network
James B Bucher Owned Company Details
What does Eliem Therapeutics Inc do?
Who are the key executives at Eliem Therapeutics Inc?
James B Bucher is the EVP and General Counsel of Eliem Therapeutics Inc. Other key executives at Eliem Therapeutics Inc include Chief Accounting Officer Emily Pimblett , director & 10 percent owner Ra Capital Healthcare Fund Lp , and 10 percent owner Ai Eti Llc .
Eliem Therapeutics Inc (ELYM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eliem Therapeutics Inc (ELYM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eliem Therapeutics Inc (ELYM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eliem Therapeutics Inc (ELYM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eliem Therapeutics Inc Insider Transactions
James B Bucher Mailing Address
Above is the net worth, insider trading, and ownership report for James B Bucher. You might contact James B Bucher via mailing address: 11804 North Creek Parkway S, Bothell Wa 98011.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
